Global Galectin 3 Market By Product Type (GAL-300, GRMD-03) And By End-Users/Application (Liver Cirrhosis, Portal Hypertension) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Galectin 3 market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Galectin 3 market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Galectin 3 industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Galectin 3 ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Galectin 3 market.

The following manufacturers are covered in this report:
  • Angion Biomedica Corp
  • Bristol-Myers Squibb Company
  • Galectin Therapeutics Inc
  • GlycoMimetics Inc
  • iTeos Therapeutics SA
  • MandalMed Inc

The report estimates on the Galectin 3 market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Galectin 3 market report consist of all leading industry players, Galectin 3 business sections, company profile, revenue supply by Galectin 3 industry sections, global Galectin 3 market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Galectin 3 market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Galectin 3 market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Galectin 3 market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Galectin 3 market.

Report Opportunity: Global Galectin 3 Market

This report delivers an analytical examination of the Galectin 3 market summarized in broad sections such as
  1. Galectin 3 Market Summary
  2. Key Commercial Growths in the Galectin 3 Industry
  3. Market Dynamics Affecting the Galectin 3 Industry
  4. Important Market Trends and Future Development Scenario of the Galectin 3 Market
  5. Galectin 3 Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Galectin 3 Industry
  7. Positioning of Main Market Players in the Galectin 3 Industry
  8. Galectin 3 Market Revenue and Forecast, by Application, 2018 - 2028
  9. Galectin 3 Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Galectin 3 Market Revenue and Forecast, by Geography, 2018 - 2028
Galectin 3 Market Segmentation:

The report provides detailed examination of the Galectin 3 market on the basis of various segments such as type, application and end-use industry. The Galectin 3 market is segmented as follows:

Galectin 3 Market, by Type:
  • GAL-300
  • GRMD-03
  • ANG-4021
  • KTI
  • Others
Galectin 3 Market, by Application:
  • Liver Cirrhosis
  • Portal Hypertension
  • Metastatic Melanoma
  • Others
Geographic Coverage

The report on the Galectin 3 market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Galectin 3 Market Revenue and Forecast
  • U.S.
  • Canada
Europe Galectin 3 Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Galectin 3 Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Galectin 3 Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Galectin 3 Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Galectin 3 Market Snapshot
          2.1.1. Global Galectin 3 Market By Type,2019
               2.1.1.1.GAL-300
               2.1.1.2.GRMD-03
               2.1.1.3.ANG-4021
               2.1.1.4.KTI
               2.1.1.5.Others
          2.1.2. Global Galectin 3 Market By Application,2019
               2.1.2.1.Liver Cirrhosis
               2.1.2.2.Portal Hypertension
               2.1.2.3.Metastatic Melanoma
               2.1.2.4.Others
          2.1.3. Global Galectin 3 Market By End-use,2019
          2.1.4. Global Galectin 3 Market By Geography,2019

3. Global Galectin 3 Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Galectin 3 Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Galectin 3 Market Size (US$), By Type, 2018 – 2028

5. Global Galectin 3 Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Galectin 3 Market Size (US$), By Application, 2018 – 2028

6. Global Galectin 3 Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Galectin 3 Market Size (US$), By End-use, 2018 – 2028

7. Global Galectin 3 Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Galectin 3 Market Analysis, 2018 – 2028 
          7.2.1. North America Galectin 3 Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Galectin 3 Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Galectin 3 Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Galectin 3 Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Galectin 3 Market Analysis, 2018 – 2028 
          7.3.1.  Europe Galectin 3 Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Galectin 3 Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Galectin 3 Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Galectin 3 Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Galectin 3 Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Galectin 3 Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Galectin 3 Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Galectin 3 Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Galectin 3 Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Galectin 3 Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Galectin 3 Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Galectin 3 Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Galectin 3 Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Galectin 3 Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Galectin 3 Market Analysis, 2018 – 2028 
          7.6.1.  MEA Galectin 3 Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Galectin 3 Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Galectin 3 Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Galectin 3 Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Galectin 3 Providers
        8.4.1 Angion Biomedica Corp
                8.1.1 Business Description
                8.1.2 Angion Biomedica Corp Geographic Operations
                8.1.3 Angion Biomedica Corp Financial Information
                8.1.4 Angion Biomedica Corp Product Positions/Portfolio
                8.1.5 Angion Biomedica Corp Key Developments
        8.4.2 Bristol-Myers Squibb Company
                8.2.1 Business Description
                8.2.2 Bristol-Myers Squibb Company Geographic Operations
                8.2.3 Bristol-Myers Squibb Company Financial Information
                8.2.4 Bristol-Myers Squibb Company Product Positions/Portfolio
                8.2.5 Bristol-Myers Squibb Company Key Developments
        8.4.3 Galectin Therapeutics Inc
                8.3.1 Business Description
                8.3.2 Galectin Therapeutics Inc Geographic Operations
                8.3.3 Galectin Therapeutics Inc Financial Information
                8.3.4 Galectin Therapeutics Inc Product Positions/Portfolio
                8.3.5 Galectin Therapeutics Inc Key Developments
        8.4.4 GlycoMimetics Inc
                8.4.1 Business Description
                8.4.2 GlycoMimetics Inc Geographic Operations
                8.4.3 GlycoMimetics Inc Financial Information
                8.4.4 GlycoMimetics Inc Product Positions/Portfolio
                8.4.5 GlycoMimetics Inc Key Developments
        8.4.5 iTeos Therapeutics SA
                8.5.1 Business Description
                8.5.2 iTeos Therapeutics SA Geographic Operations
                8.5.3 iTeos Therapeutics SA Financial Information
                8.5.4 iTeos Therapeutics SA Product Positions/Portfolio
                8.5.5 iTeos Therapeutics SA Key Developments
        8.4.6 MandalMed Inc
                8.6.1 Business Description
                8.6.2 MandalMed Inc Geographic Operations
                8.6.3 MandalMed Inc Financial Information
                8.6.4 MandalMed Inc Product Positions/Portfolio
                8.6.5 MandalMed Inc Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Galectin 3 Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Galectin 3 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Galectin 3 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Galectin 3 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Galectin 3 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Galectin 3 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Galectin 3 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Galectin 3 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Galectin 3 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Galectin 3 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Galectin 3 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Galectin 3 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Galectin 3 Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Galectin 3 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Galectin 3 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Galectin 3 Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Galectin 3: Market Segmentation 
FIG. 2 Global Galectin 3 Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Galectin 3 Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Galectin 3 Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Galectin 3 Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Galectin 3 Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Galectin 3 Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Galectin 3 Providers, 2019
FIG. 11 Global Galectin 3 Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Galectin 3 Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Galectin 3 Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Galectin 3 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Galectin 3 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Galectin 3 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Galectin 3 Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Galectin 3 Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Galectin 3 market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
6099

1421

OUR CLIENT